Siste oppdatering :
08/05/2024
Fungicid   Voriconazole  
Injeksjon
Salver Øyedråper
Oppløsningsstabilitet Stabilitet i blandinger Faktorer som påvirker stabiliteten Kompatibilitet Administrasjonsmåte Referanser Pdf
   Kjemisk struktur  

Handelsnavn   Handelsnavn     

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

Candiox Ecuador
Ekomikane Mexico
Fusitop Chile
Vfend Argentina, Australia, Belgia, Canada, Chile, Colombia, Danmark, De forente arabiske emirater, Ecuador, Egypt, Finland, Frankrike, Hellas, Iran, Irland, Island, Italia, Japan, Luxembourg, Malaysia, Marokko, Mexico, Nederland, New Zealand, Norge, Polen, Portugal, Romania, Saudi-Arabia, Spania, Storbritannia, Sveits, Sverige, Tunisia, Tyrkia, Tyskland, Ungarn, USA, Venezuela, Østerrike
Viradep Chile
Vorazyr Tyrkia
Vorcum Venezuela
Voriole Chile
Vorix Tyrkia
Vorzole Peru
Zivenad Chile
Referanser   Injeksjon   Referanser : Voriconazole  
Type Publikasjon
1982 Journal Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2017 Journal Barker B, Feddema S, Rusho WJ, Dengg R.
Visual compatibility of vasopressin with other injectable drugs.
Am J Health-Syst Pharm 2005 ; 62: 1969-1976.
2111 Journal Cadrobbi J, Hecq JD, Lebrun C, Vanbeckbergen D, Jamart J, Galanti L.
Long-term stability of voriconazole 4 mg/ml in dextrose 5% polyvinyl chloride bags at 4°C.
EJHP Science 2006 ; 12, 3: 57-59.
2131 Journal Sahraoui L, Chiadmi F, Schlatter J, Toledano A, Cisternino S, Fontan JE.
Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections.
Am J Health-Syst Pharm 2006 ; 63: 1423-1426.
2233 Journal Condie C.K, Tyler L.S, Barker B, Canann D.M.
Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery
Am J Health-Syst Pharm 2008 ; 65, 5: 454-457.
2247 Journal Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262 Journal Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2269 Journal Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H.
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3012 Journal Sullivan T, Forrest J.M, Leclair G.
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration
Hosp Pharm 2015 ; 50, 3: 214-220.
3087 Journal Adams, A.I.H., Morimoto, L.N., Meneghini, L.Z., Bergold, A.M.
Treatment of invasive fungal infections: Stability of voriconazole infusion solutions in PVC bags.
BJID 2008 ; 12, 5: 400-404.
3249 Journal Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB.
Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3408 Journal Tollec S, Touzin K, Pelletier E, Forest J.M.
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Pharmactuel 2013 ; 46, 1 : 16-21.
3566 Labratorium Voriconazole (Vfend®) - Summary of Product characteristics.
Pfizer 2013
3824 Journal Boudi S, Roy H, Forest JM, Leclair G.
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Pharmactuel 2023 2023;56,3:91-98
3964 Journal Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Pharmactuel 2017 ; 50,1 : 27-33.
3975 Plakat Roche M, Simon N, Bourdon F, Dhorne C, Berneron C, Lannoy D, Odou P.
Stability of 50 and 100 µg/0,1mL intraocular solutions of voriconazole at 2-8°C.
EAHP congress - Cannes 2017
4035 Journal Harmanjeet H, Zaidi S.T.R, Ming L.C, Wanandy T, Patel R.P.
Physicochemical stability of voriconazole in elastomeric devices.
EJHP 2017 ;0:1-5
4254 Journal D'Huart E, Vigneron J, Demoré B.
Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs
Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40
4319 Journal Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4528 Journal Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4603 Journal Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Hosp Pharm 2021 ; 56, 4: 228-234.
4633 Journal Reber E, Neyer P, Schönenberger K.A, Saxer C, Bernasconi L, Stanga Z, Huber A, Hammerer-Lercher A, Mühlebach S.
Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures.
Pharmaceutics 2021 ; 13, 1447.
4742 Journal Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.

  Mentions Légales